price month
 close
ep shortfal rev profit new order
ep consensu petss ep
miss estim weaker revenu profit
lower ep reflect miss well
increment revenu profit headwind amidst heighten competit
tp move lower view maintain
cautiou bia stock multipl competit fundament
challeng evolv on-line pet medic landscap
revenu fell well plan estimate deterior new
order sale vs estimate weaker expect reorder sale
vs estimate new custom drop well plan
gross margin deterior bp y/i bp wors
plan increment discounts/promot admin expens fell bp
albeit bp plan advertis spend fell bp bp
plan ebitda margin deterior bp bp plan
flow million help fund dividend million
cash reserv stand million
share retreat share declin recent
high nov vs expect share declin
latest quarterli miss weaker expect perform across
nearli everi line item aggress discount promot weigh
notabl gross margin deterior new custom
lowest trend sinc drove custom acquisit cost higher
trend suspect continu shift costli offlin
advertis strategi year continu face sever challeng
esrx/petco new retail/e-commerc concept limit offset
nt view risk industri consolid shift competit dynam
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
oper lead pet pharmaci us
market prescript over-the-counter pet medic
market dynam competitor signific rebound new
custom order meaning margin expans success
advertis promot strategi better expect
strength across anim health industri
veterinarian distributor manufactur rise custom
acquisit cost inventori disrupt unexpect
deterior broader anim health fundament
price jan rate under-perform target price analyst erin wright
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ activ
effect exchang rate
chang net cash/debt
net debt end
total liabil equiti
share wtd average
 close
compani data credit suiss estim million
compani mention price
